$35.21 $0.19 per serving
Product analysis
Super Fisol Fish Oil provides EPA and DHA with favorable value for EPA and reasonable value for DHA. The oil forms are not specified, making it harder to compare how the body may use them.
AI assessment of the formula, label and price. How scoring works
Nutrient Quality20
The EPA and DHA forms are not specified, leaving their ease of use by the body uncertain. The other fat listings do not establish a clear oil-quality advantage.
Ingredient Transparency32
The EPA and DHA amounts are disclosed, helping you compare the main omega-3 content. Several other amounts and mixture details are missing, and the oil forms are not specified.
Value For Money65
EPA is the stronger value feature, while DHA offers reasonable value. The other listed fats do not have reliable value comparisons.
Customer Satisfaction73
Customer feedback is generally positive. The number of reviews gives more context to satisfaction but does not establish effectiveness or safety.
Product Focus68
The main ingredients have support for one intended goal, though benefits are uncertain. None of the listed ingredients is confirmed to be unnecessary.
- Format
Softgel - Container
- 180 Softgel(s)
- Per serving
- $0.19
- Customer rating
- 4.6 · 364 ratings
Goals
Impact
High effect
Fish Oil · 500 mg
EPA and DHA have evidence for lowering triglycerides, but the small disclosed serving amounts are well below the purified active exposures used in the cited trials. The saved finding therefore gives only partial recognition to the amounts. This does not establish a measured triglyceride response at this serving or prevention of cardiovascular events.
How this product is rated for Cardiovascular Support
Ingredient fit67
The formula contains ingredients relevant to skin nutrition. Their amounts and the presence of other actives determine how focused this finding is.
Goal fit
The relevant ingredients dominate the formula, although the product may also be linked to other goals.
Dose adequacy
The disclosed amounts provide partial support; smaller or unresolved quantities limit the amount finding.
Pathways42
The strongest recorded coverage concerns triglyceride metabolism; this is a mechanism finding, not proof of fewer cardiovascular events.
Depth
The strongest recorded coverage concerns triglyceride metabolism; this is a mechanism finding, not proof of fewer cardiovascular events.
Breadth
One cardiovascular mechanism reaches the coverage threshold, with limited coverage of the others.
Evidence83
EPA declared active provides the strongest recognized evidence contribution, subject to the ingredient-specific population and preparation limits.
Evidence strength
EPA declared active provides the strongest recognized evidence contribution, subject to the ingredient-specific population and preparation limits.
Studied preparation
The saved result accepts the relevant preparations, although this does not establish that the finished product matches a skin trial.
Formulation logic100
The included ingredients have no recorded missing partners or configured conflicts. Amount limitations are retained separately.
Partner coverage
No missing required ingredient partner limits the saved finding; this does not establish an added combination benefit.
Conflicts
No configured ingredient conflict was identified in the supplied evaluation.
Effective doses
All ingredients included in this finding meet the saved minimum amount threshold, without proving a clinical response.
Ingredients
| Ingredient | Amount per serving | Score |
|---|---|---|
Calories | 5 Calorie(s) | |
Total Fat | 0.5 Gram(s) | |
Saturated Fat | 0 Gram(s) | |
Trans Fat | 0 Gram(s) | |
Polyunsaturated Fat | 0 Gram(s) | |
Monounsaturated Fat | 0 Gram(s) | |
Cholesterol | 5 mg | |
Fish Oil | 500 mg | |
Omega-3 Fatty Acids | 350 mg | |
Eicosapentaenoic Acid | 200 mg | |
Docosahexaenoic Acid | 150 mg |
Omega-3 · 350 mg OverallScore70
EPA (Eicosapentaenoic Acid) · 200 mg OverallScore57
A softgel supplies a modest 200 mg of EPA from 500 mg of fish oil. An antioxidant combination is recorded, but molecular form and qualifying contaminant-testing evidence remain unestablished in the saved facts.
How this ingredient is rated
Active Ingredient Quality & Bioavailability68
EPA makes up about 40.0% of the fish oil. Its molecular form remains unspecified.
Molecular Form and Bioavailability
The molecular form is unspecified in the saved facts, so triglyceride, phospholipid or ethyl ester identity cannot be established.
EPA Concentration Density
EPA accounts for about 40.0% of the declared fish-oil amount, distinguishing EPA quantity from total oil.
Oxidation Protection
Tocopherols and another recognized antioxidant are recorded as ingredients; their presence does not establish measured oil freshness.
Dose, Safety & Label Transparency36
The 200 mg EPA amount is clearly stated, with somewhat more EPA than DHA. Qualifying contaminant-testing evidence is unavailable in the saved facts.
Absolute EPA Dose per Serving
A serving supplies 200 mg of EPA, separate from the total fish-oil or omega-3 amount.
EPA-Centric Ratio
The serving contains 200 mg EPA and 150 mg DHA, with somewhat more EPA than DHA.
Purity and Contaminant Testing
The saved facts do not establish an oil-purification claim or qualifying third-party contaminant-testing evidence.
Value80
The whole-product cost is favorable for the EPA supplied.
Price per Gram of EPA
The whole-product cost works out to about $0.98 per gram of EPA, including its other ingredients.
Fish Oil · 500 mg OverallScore56
Alternative products
Report alternatives
Sources
Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.
- Marine Omega-3 Supplementation and Cardiovascular Disease: An Updated Meta-Analysis of 13 Randomized Controlled Trials Involving 127 477 Participants.
- Impact of omega-3 fatty acids on hypertriglyceridemia, lipidomics, and gut microbiome in patients with type 2 diabetes.
- A systematic review of fish-oil supplements for the prevention and treatment of hypertension.
- Effects of fish oil-derived fatty acids on suboptimal cardiovascular health: A multicenter, randomized, double-blind, placebo-controlled trial.
- Effect of High-Dose Marine Omega-3 Fatty Acids on Atherosclerosis: A Systematic Review and Meta-Analysis of Randomized Clinical Trials.